Investing.com -- Shares of RxSight saw a record intraday drop of as much as 21% in the wake of the company's announcement of its preliminary revenue for both the fourth quarter and the full year, which fell short of the average analyst predictions.
The company's projected revenue for the fourth quarter stands at $40.2 million, slightly below the Bloomberg consensus estimate of $40.4 million.
Looking further ahead, RxSight also provided its preliminary revenue forecast for the year 2024. The company expects to generate $139.9 million, a figure that falls short of the estimated $140.1 million.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.